BACKGROUND & AIMS: Although the incidence of hepatocellular carcinoma (HCC) is
increasing in the United States, data from large prospective studies are limited. We evaluated the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease 2019 (COVID-19), is associated with respiratory-related disease and …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

Retrospective studies suggest that subjects with chronic hepatitis C and advanced fibrosis
who achieve a sustained virological response (SVR) have a lower risk of hepatic …

Background & Aims: The most effective therapy currently available for treatment of chronic
hepatitis C virus (HCV) is the combination of peginterferon and ribavirin. This study evaluated …

Background In patients with chronic hepatitis C who do not have a response to antiviral
treatment, the disease may progress to cirrhosis, liver failure, hepatocellular carcinoma, and …

Abstract Knowledge of the presence of cirrhosis is important for the management of patients
with chronic hepatitis C (CHC). Most models for predicting cirrhosis were derived from small …

Silymarin, also known as milk thistle extract, inhibits hepatitis C virus (HCV) infection and
also displays antioxidant, anti-inflammatory, and immunomodulatory actions that contribute to …

Background & Aims: Chronic hepatitis C is a serious global medical problem necessitating
effective treatment. Because standard of care with pegylated interferon plus ribavirin therapy …

Background SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), is associated
with respiratory-related morbidity and mortality. Assays to detect virus-specific antibodies …